FDA OKs drug for pain during sex for postmenopausal women

02/26/2013 | CBS News · Drug Store News

Shionogi's Osphena, or ospemifene, has been approved by the FDA to treat dyspareunia, a condition characterized by pain during sex, in postmenopausal women. The drug gives patients another option for treatment, FDA Office of Drug Evaluation Deputy Director Victoria Kusiak said.

View Full Article in:

CBS News · Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD